This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gilead Palo Alto, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hsiao Dee Lieu: Innovator in Cardiovascular Pharmacology
Introduction
Hsiao Dee Lieu is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of cardiovascular pharmacology, particularly through his innovative patent related to adenosine receptor agonists. His work aims to improve coronary vasodilation while minimizing peripheral vasodilation.
Latest Patents
Hsiao Dee Lieu holds a patent for the "Use of A2A adenosine receptor agonists." This invention focuses on methods for producing coronary vasodilation by administering doses of a pharmaceutical composition that includes regadenoson. The patent specifies that the composition should be administered in an amount sufficient to increase the average coronary peak flow velocity by at least about 16.5 cm/sec.
Career Highlights
Currently, Hsiao Dee Lieu is associated with Gilead Palo Alto, Inc., where he continues to advance his research in pharmacology. His work has the potential to significantly impact treatments for cardiovascular conditions.
Collaborations
Hsiao Dee Lieu collaborates with esteemed colleagues such as Ann Walls Olmsted and Toufigh Gordi. Their combined expertise enhances the innovative efforts within their research environment.
Conclusion
Hsiao Dee Lieu's contributions to cardiovascular pharmacology through his patent demonstrate his commitment to advancing medical science. His work is poised to make a meaningful difference in the treatment of coronary conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile